Acute myelogenous leukemia stem cells: from Bench to Bedside.
about
CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cellsConcise review: Leukemia stem cells in personalized medicineUpdate on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunitiesStem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 SpeciesA combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemiaAntibody therapy for acute myeloid leukaemia.Inhibitors of emerging epigenetic targets for cancer therapy: a patent review (2010-2014).Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.GPR56 contributes to the development of acute myeloid leukemia in mice.Therapeutic targeting of CK2 in acute and chronic leukemias.Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells.
P2860
Q24336990-FC95DAFF-44EC-4C41-8130-70A7C88424E7Q26995268-8235536B-4D1C-4D3A-96A8-E03BEB02DFD5Q28071384-6D195F77-7F65-4957-9B1B-1B037A42EA8AQ33653485-97A74EA3-3172-4938-9466-EF2C92497468Q34047994-41830AEF-47D7-468C-9E3A-28618A7A6470Q34715598-552999A9-4485-4CBB-84FC-53BB6873AB0FQ35300118-A09ACA1A-9C34-4378-829A-A47B5D9D7A41Q36426254-C66EEE19-AF72-45E1-8CE7-96522135D588Q36926129-F5D17DEA-4357-4252-8B75-616390023ED2Q38169814-13430244-F79C-479C-800A-D972A4147457Q38547122-30AAF69C-7533-405D-B1E9-A6AE57C77B41Q39016197-D1B55A8A-1F98-48F7-9C11-372BD7D88198Q39809596-D215DE6F-1DE0-417A-90C3-9DB9D20C40C7Q40118769-A60E808B-C19F-4E3D-B8E4-5391B55CABB8Q40808168-9F7935D6-38C0-4679-8B0C-8FF9BF463777Q47677919-12FB0D8E-D423-4513-ADCB-6CEDE92129DEQ49334989-DBD7BA9D-623A-4867-A1D4-76AA6C8EEDC2Q55709078-ADC2310E-4473-4410-A763-1E00C038266B
P2860
Acute myelogenous leukemia stem cells: from Bench to Bedside.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Acute myelogenous leukemia stem cells: from Bench to Bedside.
@en
type
label
Acute myelogenous leukemia stem cells: from Bench to Bedside.
@en
prefLabel
Acute myelogenous leukemia stem cells: from Bench to Bedside.
@en
P2860
P1433
P1476
Acute myelogenous leukemia stem cells: from Bench to Bedside
@en
P2093
J Felipe Rico
Monica L Guzman
P2860
P356
10.1016/J.CANLET.2012.05.034
P407
P577
2012-06-17T00:00:00Z